CKD-EPI creatinine equation (2009)
The CKD-EPI creatinine equation is based on the same four variables as the MDRD Study equation, but uses a 2-slope spline to model the relationship between estimated GFR and serum creatinine, and a different relationship for age, sex and race. The equation was reported to perform better and with less bias than the MDRD Study equation, especially in patients with higher GFR. This results in reduced misclassification of CKD.
Tyrimų autoriai: Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, and Coresh J.
Versija: 1.16
  • Viešoji svetainė
  • Nefrologija
  • {{ modelType }}
  • Išsami informacija
  • Patvirtinti modelį
  • Išsaugoti įvestį
  • Įkrovos įvestis

Apskaičiuokite rezultatą

Nustatykite daugiau parametrų skaičiavimams atlikti

Estimated GFR: ml/min/1.73m2

{{ resultSubheader }}
{{ chart.title }}
Rezultatų intervalas {{ additionalResult.min }} į {{ additionalResult.max }}

Sąlyginė informacija

The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation was developed in an effort to create a more precise formula to estimate glomerular filtrate rate (GFR) from serum creatinine and other readily available clinical parameters, especially at when actual GFR is >60 mL/min per 1.73m2.

Researchers pooled data from multiple studies to develop and validate this new equation. They randomly divided 10 studies which included 8254 participants, into separate data sets for development and internal validation. 16 additional studies, which included 3896 participants, were used for external validation.

The CKD-EPI equation performed better than the MDRD (Modification of Diet in Renal Disease Study) equation, especially at higher GFR, with less bias and greater accuracy. When looking at NHANES (National Health and Nutrition Examination Survey) data, the median estimated GFR was 94.5 mL/min per 1.73 m2 vs. 85.0 mL/min per 1.73 m2, and the prevalence of chronic kidney disease was 11.5% versus 13.1%.

{{ file.classification }}
PRO
Pastaba
Pastabos matomos tik rezultatų atsisiuntimo metu ir \"Evidencio\" jų neišsaugo.

Šis modelis pateikiamas švietimo, mokymo ir informavimo tikslais. Jis neturi būti naudojamas medicininiams sprendimams priimti arba medicininėms ar diagnostinėms paslaugoms teikti. Perskaitykite visą mūsų disclaimer.

Pagrindiniai modeliai Dalis
Komentarai
Komentaras
Įveskite komentarą
Komentarai matomi visiems

Atsiliepimai apie modelį

Atsiliepimų dar nėra 1 komentaras {{ model.comments.length }} Komentarai
Svetainėje {{ comment.created_at }} {{ comment.user.username }} nebeužregistruotas autorius rašė:
{{ comment.content }}
logo

Prisijunkite, kad įjungtumėte \"Evidencio\" spausdinimo funkcijas

Kad galėtumėte naudotis \"Evidencio\" spausdinimo funkcijomis, turite būti prisijungę.
Jei neturite \"Evidencio\" bendruomenės paskyros, galite susikurti nemokamą asmeninę paskyrą adresu:

https://www.evidencio.com/registration.

Atspausdinti rezultatai - Pavyzdžiai {{ new Date().toLocaleString() }}


\"Evidencio\" bendruomenės paskyros privalumai


With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.


Atsakomybės apribojimas: vien tik skaičiavimai niekada neturėtų nulemti pacientų priežiūros ir negali pakeisti profesionalaus vertinimo.
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved